Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-year follow-up from a randomized, controlled study.

Ujeyl A, Fang JC, Desai AS, Mudge GH Jr, Givertz MM.

J Heart Lung Transplant. 2011 Oct;30(10):1200-1. doi: 10.1016/j.healun.2011.07.016. No abstract available.

PMID:
21962021
2.

Intractable cardiac arrest due to lidocaine toxicity successfully resuscitated with lipid emulsion.

Dix SK, Rosner GF, Nayar M, Harris JJ, Guglin ME, Winterfield JR, Xiong Z, Mudge GH Jr.

Crit Care Med. 2011 Apr;39(4):872-4. doi: 10.1097/CCM.0b013e318208eddf.

PMID:
21263316
3.

Ventricular assist devices the challenges of outpatient management.

Wilson SR, Givertz MM, Stewart GC, Mudge GH Jr.

J Am Coll Cardiol. 2009 Oct 27;54(18):1647-59. doi: 10.1016/j.jacc.2009.06.035. Review.

4.

Management of end-stage heart failure: a perspective on the Arab Gulf states.

Al Habeeb W, Stewart GC, Mudge GH.

Ann Saudi Med. 2009 Nov-Dec;29(6):460-6. doi: 10.4103/0256-4947.57169. Review.

5.

Thresholds of physical activity and life expectancy for patients considering destination ventricular assist devices.

Stewart GC, Brooks K, Pratibhu PP, Tsang SW, Semigran MJ, Smith CM, Saniuk C, Camuso JM, Fang JC, Mudge GH, Couper GS, Baughman KL, Stevenson LW.

J Heart Lung Transplant. 2009 Sep;28(9):863-9. doi: 10.1016/j.healun.2009.05.016.

PMID:
19716036
6.

Evaluation for a ventricular assist device: selecting the appropriate candidate.

Wilson SR, Mudge GH Jr, Stewart GC, Givertz MM.

Circulation. 2009 Apr 28;119(16):2225-32. doi: 10.1161/CIRCULATIONAHA.109.850610. Review. No abstract available.

PMID:
19398678
7.

Sirolimus and cardiac transplantation: is it the "magic bullet"?

Mudge GH Jr.

Circulation. 2007 Dec 4;116(23):2666-8. No abstract available.

PMID:
18056538
8.

The physiologic basis for the management of ventricular assist devices.

Mudge GH Jr, Fang JC, Smith C, Couper G.

Clin Cardiol. 2006 Jul;29(7):285-9. Review.

9.

BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis.

Pendse SS, Vadivel N, Ramos E, Mudge GH, Von Visger T, Fang JC, Chandraker A.

J Heart Lung Transplant. 2006 Jul;25(7):814-9.

PMID:
16818124
10.

The management of mechanical hearts.

Mudge GH Jr.

Trans Am Clin Climatol Assoc. 2005;116:283-91; discussion 292.

11.

Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium.

Teuteberg JJ, Lewis EF, Nohria A, Tsang SW, Fang JC, Givertz MM, Jarcho JA, Mudge GH, Baughman KL, Stevenson LW.

J Card Fail. 2006 Feb;12(1):47-53.

PMID:
16500580
12.

Severity of intraoperative tricuspid regurgitation predicts poor late survival following cardiac transplantation.

Anderson CA, Shernan SK, Leacche M, Rawn JD, Paul S, Mihaljevic T, Jarcho JA, Stevenson LW, Fang JC, Lewis EF, Couper GS, Mudge GH, Byrne JG.

Ann Thorac Surg. 2004 Nov;78(5):1635-42.

PMID:
15511447
13.

Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation.

Byrne JG, Leacche M, Paul S, Mihaljevic T, Rawn JD, Shernan SK, Mudge GH, Stevenson LW.

Eur J Cardiothorac Surg. 2004 Mar;25(3):327-32.

PMID:
15019656
14.

Frequency and impact of delayed decisions regarding heart transplantation on long-term outcomes in patients with advanced heart failure.

Lewis EF, Tsang SW, Fang JC, Mudge GH, Jarcho JA, Flavell CM, Nohria A, Givertz MM, Couper GS, Byrne JG, Warner Stevenson L.

J Am Coll Cardiol. 2004 Mar 3;43(5):794-802.

15.

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure.

Nohria A, Tsang SW, Fang JC, Lewis EF, Jarcho JA, Mudge GH, Stevenson LW.

J Am Coll Cardiol. 2003 May 21;41(10):1797-804.

16.

Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial.

Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P.

Lancet. 2002 Mar 30;359(9312):1108-13.

PMID:
11943259
17.

30th Bethesda Conference: The Future of Academic Cardiology. Task force 1: clinical care.

DeMots H, Mudge GH Jr.

J Am Coll Cardiol. 1999 Apr;33(5):1098-109. No abstract available.

PMID:
10193705
18.

Noninvasive assessment of transplant-associated arteriosclerosis.

Fang JC, Rocco T, Jarcho J, Ganz P, Mudge GH.

Am Heart J. 1998 Jun;135(6 Pt 1):980-7. Review.

PMID:
9630101
19.

Hemostatic/fibrinolytic predictors of allograft coronary artery disease after cardiac transplantation.

Meckel CR, Anderson TJ, Mudge GH, Mitchell RN, Yeung AC, Selwyn AP, Ganz P, Simon DI.

Vasc Med. 1997 Nov;2(4):306-12.

PMID:
9575604
20.

Changing patterns in donor and recipient risk: a 10-year evolution in one heart transplant center.

Hauptman PJ, Kartashov AI, Couper GS, Mudge GH Jr, Aranki SF, Cohn LH, Adams DH.

J Heart Lung Transplant. 1995 Jul-Aug;14(4):654-8.

PMID:
7578171
21.

Cardiomyopathy of limb-girdle muscular dystrophy.

Mascarenhas DA, Spodick DH, Chad DA, Gilchrist J, Townes PL, DeGirolami U, Mudge GH, Maki DW, Bishop RL.

J Am Coll Cardiol. 1994 Nov 1;24(5):1328-33.

22.

T cell activation in cardiac transplant recipients.

McKay DB, Milford EL, Carpenter CB, Kartashov AI, Schoen FJ, Loh E, Aranki SF, Couper GS, Mudge GH.

Transplantation. 1994 Jul 27;58(2):241-5. No abstract available.

PMID:
8042242
23.

Pericardial effusions after cardiac transplantation.

Hauptman PJ, Couper GS, Aranki SF, Kartashov A, Mudge GH Jr, Loh E.

J Am Coll Cardiol. 1994 Jun;23(7):1625-9.

24.

Asymptomatic mitral regurgitation: when to operate?

Mudge GH Jr.

J Card Surg. 1994 Mar;9(2 Suppl):248-51.

PMID:
8186576
25.

Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation.

Loh E, Bergin JD, Couper GS, Mudge GH Jr.

J Heart Lung Transplant. 1994 Mar-Apr;13(2):194-201.

PMID:
8031799
26.

Early cardiac allograft failure after orthotopic heart transplantation.

Hauptman PJ, Aranki S, Mudge GH Jr, Couper GS, Loh E.

Am Heart J. 1994 Jan;127(1):179-86. Review.

PMID:
8273737
27.

Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation.

Anderson TJ, Meredith IT, Uehata A, Mudge GH, Selwyn AP, Ganz P, Yeung AC.

Circulation. 1993 Sep;88(3):1093-100.

PMID:
8353871
28.

24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization.

Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME Jr, Stevenson LW.

J Am Coll Cardiol. 1993 Jul;22(1):21-31. No abstract available.

29.

Sinoatrial and atrioventricular block caused by intracoronary infusion of adenosine early after heart transplantation.

Anderson TJ, Ryan TJ Jr, Mudge GH, Selwyn AP, Ganz P, Yeung AC.

J Heart Lung Transplant. 1993 May-Jun;12(3):522-4.

PMID:
8329431
30.

Loss of the coronary microvascular response to acetylcholine in cardiac transplant patients.

Treasure CB, Vita JA, Ganz P, Ryan TJ Jr, Schoen FJ, Vekshtein VI, Yeung AC, Mudge GH, Alexander RW, Selwyn AP, et al.

Circulation. 1992 Oct;86(4):1156-64.

PMID:
1394923
31.

Strategies to manage the heart failure patient after transplantation.

Mudge GH Jr.

Clin Cardiol. 1992 Sep;15 Suppl 1:I37-41. Review.

32.

Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients.

Rich GM, Mudge GH, Laffel GL, LeBoff MS.

J Heart Lung Transplant. 1992 Sep-Oct;11(5):950-8.

PMID:
1420244
33.

Endothelial dysfunction in the development and detection of transplant coronary artery disease.

Yeung AC, Anderson T, Meredith I, Uehata A, Ryan TJ Jr, Selwyn AP, Mudge GH, Ganz P.

J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 2):S69-73. Review. No abstract available.

PMID:
1623004
34.

The role of endothelial dysfunction to predict the development of allograft coronary artery disease following cardiac transplantation.

Mudge GH Jr, Yeung A, Selwyn AP, Ganz P.

Trans Am Clin Climatol Assoc. 1992;103:105-10. No abstract available.

35.

Serial assessment of left ventricular function and mass after orthotopic heart transplantation: a 4-year longitudinal study.

Tischler MD, Lee RT, Plappert T, Mudge GH, St John Sutton M, Parker JD.

J Am Coll Cardiol. 1992 Jan;19(1):60-6. Erratum in: J Am Coll Cardiol 1994 Jan;23(1):281.

36.

Arteriosclerosis in transplanted hearts: too much and too soon.

Libby P, Pober JS, Swanson SJ, Mudge GH Jr, Schoen FJ.

Can J Cardiol. 1991 Apr;7(3):XI-XII. No abstract available.

PMID:
2044011
37.

Fatal pulmonary venoocclusive disease secondary to a generalized venulopathy: a new syndrome presenting with facial swelling and pericardial tamponade.

Liang MH, Stern S, Fortin PR, Louie DC, Marsh JD, Mudge GH Jr, Murphy G.

Arthritis Rheum. 1991 Feb;34(2):228-33.

PMID:
1994922
38.

Results of heart transplantation for active lymphocytic myocarditis.

O'Connell JB, Dec GW, Goldenberg IF, Starling RC, Mudge GH, Augustine SM, Costanzo-Nordin MR, Hess ML, Hosenpud JD, Icenogle TB, et al.

J Heart Transplant. 1990 Jul-Aug;9(4):351-5; discussion 355-6.

PMID:
2398428
39.

Ruptured chordae tendineae of the tricuspid valve as a complication of endomyocardial biopsy in heart transplant patients.

Braverman AC, Coplen SE, Mudge GH, Lee RT.

Am J Cardiol. 1990 Jul 1;66(1):111-3. No abstract available.

PMID:
2360527
40.

Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.

Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, Sutton MG, Selwyn AP, Alexander RW, et al.

Circulation. 1990 Mar;81(3):772-9.

PMID:
2306829
41.

HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation.

DiSesa VJ, Kuo PC, Horvath KA, Mudge GH, Collins JJ Jr, Cohn LH.

Ann Thorac Surg. 1990 Feb;49(2):220-3; discussion 223-4.

PMID:
2306143
42.

Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients.

Kuo PC, Kirshenbaum JM, Gordon J, Laffel G, Young P, DiSesa VJ, Mudge GH Jr, Vaughan DE.

Am J Cardiol. 1989 Sep 15;64(10):631-5.

PMID:
2675584
43.

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise.

Gordon JB, Ganz P, Nabel EG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP.

J Clin Invest. 1989 Jun;83(6):1946-52.

44.

Management of general surgical complications following cardiac transplantation.

DiSesa VJ, Kirkman RL, Tilney NL, Mudge GH, Collins JJ Jr, Cohn LH.

Arch Surg. 1989 May;124(5):539-41.

PMID:
2653277
45.

Successful management of catastrophic intraabdominal complications following cardiac transplantation.

DiSesa VJ, Kirkman RL, Young P, Collins JJ Jr, Cohn LH, Tilney NL, Mudge GH.

Transplant Proc. 1989 Feb;21(1 Pt 3):2579-80. No abstract available.

PMID:
2650338
46.

Effect of smoking on the activity of ischemic heart disease.

Barry J, Mead K, Nabel EG, Rocco MB, Campbell S, Fenton T, Mudge GH Jr, Selwyn AP.

JAMA. 1989 Jan 20;261(3):398-402.

PMID:
2909779
47.

Power spectrum analysis of heart rate variability in human cardiac transplant recipients.

Sands KE, Appel ML, Lilly LS, Schoen FJ, Mudge GH Jr, Cohen RJ.

Circulation. 1989 Jan;79(1):76-82.

PMID:
2642758
48.

Frequency of hypercholesterolemia after cardiac transplantation.

Stamler JS, Vaughan DE, Rudd MA, Mudge GH, Kirshenbaum J, Young P, Alexander RW, Loscalzo J.

Am J Cardiol. 1988 Dec 1;62(17):1268-72.

PMID:
3057854
49.

Coronary artery fistula after mitral valve surgery.

Lee RT, Mudge GH, Colucci WS.

Am Heart J. 1988 May;115(5):1128-30. No abstract available.

PMID:
3364344
50.

Responses of coronary arteries of cardiac transplant patients to acetylcholine.

Fish RD, Nabel EG, Selwyn AP, Ludmer PL, Mudge GH, Kirshenbaum JM, Schoen FJ, Alexander RW, Ganz P.

J Clin Invest. 1988 Jan;81(1):21-31.

Supplemental Content

Loading ...
Support Center